This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should Vanguard S&P Small-Cap 600 ETF (VIOO) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VIOO
Wall Street Analysts Think e.l.f. Beauty (ELF) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for e.l.f. Beauty (ELF) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
International Flavors (IFF) Q4 Earnings Lag Estimates, Dip Y/Y
by Zacks Equity Research
International Flavors' (IFF) Q4 top line reflects softness in the Pharma and Nourish segments, offset by growth in the Scent, and Health & Biosciences segments.
Beat the Market the Zacks Way: Amazon, NVIDIA, SCREEN Holdings in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Helen of Troy (HELE) Benefits From Brand Strength & Project Pegasus
by Zacks Equity Research
Helen of Troy (HELE) is on track with Project Pegasus, which aims to expand operating margins via improved efficiency and lower costs.
TreeHouse Foods (THS) Q4 Earnings Beat, Sales Decline Y/Y
by Zacks Equity Research
TreeHouse Foods' (THS) fourth-quarter fiscal 2023 results reflect soft sales and earnings due to supply-chain hurdles at one of the broth facilities.
Service Corp (SCI) Hikes Dividend: What Else Should You Know?
by Zacks Equity Research
Service Corp (SCI) announces a dividend increase, showcasing its commitment to delivering value to its shareholders.
Nu Skin (NUS) Q4 Earnings Top Estimates, Revenues Decline Y/Y
by Zacks Equity Research
Nu Skin's (NUS) fourth-quarter 2023 results reflect the persistence of macroeconomic challenges and hurdles related to business transformation, offset by growth in some regions.
Should Invesco S&P SmallCap Momentum ETF (XSMO) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for XSMO
Zacks.com featured highlights Amazon.com, e.l.f. Beauty, Wingstop, Flowserve and NVIDIA
by Zacks Equity Research
Amazon.com, e.l.f. Beauty, Wingstop, Flowserve and NVIDIA have been highlighted in this Screen of The Week article.
Relative Strength: 3 Stocks Outperforming High-Flying Tech
by Derek Lewis
While technology stocks continue to dominate headlines thanks to their strong performances, the sector hasn't been alone in producing big-time winners over the last year.
Play Potential Earnings Beat With 5 Top-Ranked Stocks
by Sanghamitra Saha
These top-ranked stocks are likely to beat on the bottom line in their upcoming releases. Tap Amazon.com (AMZN), e.l.f. Beauty (ELF), Wingstop (WING), Flowserve (FLS) and NVIDIA (NVDA).
Should iShares Core S&P Small-Cap ETF (IJR) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IJR
3 Reasons Why Growth Investors Shouldn't Overlook e.l.f. Beauty (ELF)
by Zacks Equity Research
e.l.f. Beauty (ELF) possesses solid growth attributes, which could help it handily outperform the market.
E.l.f. Beauty (ELF) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
e.l.f. Beauty (ELF) delivered earnings and revenue surprises of 25.42% and 13.05%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
e.l.f. Beauty (ELF) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), e.l.f. Beauty (ELF) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Markets Take a Powder; PLTR, NXPI Beat in Q4
by Mark Vickery
Market indices were reluctant to drag a stock market higher amid all-time high ranges on the Dow and S&P 500.
Estee Lauder (EL) Cuts FY24 Profit View Despite Q2 Earnings Beat
by Zacks Equity Research
Estee Lauder's (EL) second-quarter fiscal 2024 results reflect lower net sales and earnings amid global macroeconomic volatility. Management lowers fiscal 2024 earnings view.
E.l.f. Beauty (ELF) Stock Moves -0.92%: What You Should Know
by Zacks Equity Research
In the latest trading session, e.l.f. Beauty (ELF) closed at $159.53, marking a -0.92% move from the previous day.
These 3 Buy-Rated Stocks Are Red-Hot
by Derek Lewis
Relative strength investing is centered around targeting stocks displaying outperformance. And when you add in the Zacks Rank, the strategy becomes even more powerful.
Coty (COTY) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Coty (COTY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Church & Dwight (CHD) Gears up for Q4 Earnings: What to Note?
by Zacks Equity Research
Church & Dwight (CHD) is likely to have seen growth in Q4 earnings, supported by strategic initiatives and consumer demand despite the potential impacts of increased expenses.
E.l.f. Beauty (ELF) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
E.l.f. Beauty (ELF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Beat the Market the Zacks Way: Rolls-Royce, Costco, e.l.f. Beauty in Focus
by Santanu Roy
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Colgate (CL) Q4 Earnings & Sales Beat Estimates, '24 View Issued
by Zacks Equity Research
Colgate's (CL) Q4 results benefited from strong sales growth, robust organic volume growth and gross and operating margin expansion.